do glp 1 medications cause cancer GLP-1 Receptor Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Risk of pancreatic cancer associated
Description
Akkermansia muciniphila
Discover insights on discontinuation rates
Learn the causes, when to worry, and how to manage it.
Trial Registration The predefined protocol has been registered in PROSPERO having registration number of CRD42023473991
When side effects occur, they are usually mild to moderate gastrointestinal symptoms (nausea, constipation, indigestion) and tend to ease as your body adjusts
